Infinity Pharmaceuticals secures extension of exclusive plan periods

By Sarah Lizee

Olympia, Wash., Feb. 13 – Infinity Pharmaceuticals, Inc. secured an extension of its exclusive periods to file and solicit votes on a Chapter 11 plan, according to an order filed Tuesday with the U.S. Bankruptcy Court for the District of Delaware.

The court extended the exclusive plan filing period through April 29 from Jan. 29 and the exclusive solicitation period through June 25 from March 27.

The company has filed a Chapter 11 plan of liquidation and disclosure statement, as previously reported.

“The complex nature of the debtors’ business and assets present unique complexity to these Chapter 11 cases,” the company said in the motion seeking the extension.

“As such, the size and complexity of these Chapter 11 cases warrant extension of the exclusive periods.”

A hearing on the plan is scheduled for March 7.

The Cambridge, Mass.-based clinical-stage biopharmaceutical company filed bankruptcy on Sept. 29 under Chapter 11 case number 23-11640.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.